How is vitamin K2 taken?
| Product | Form | MK-7 per unit | Label directions |
|---|---|---|---|
| Hatmanlabs D3 and K2 | Softgel | 200 mcg1 | One softgel daily with a meal1 |
| YYUX D3 and K2 drops | Olive oil drops2 | 50 mcg per drop2 | Adults: 1 to 2 drops once a day, or as directed by a health care practitioner, directly or mixed with a beverage2 |
| Fosteum Plus (prescription medical food, several ingredients)5 | Capsule | 90 μg per capsule, 180 μg daily5 | Twice a day about 12 hours apart, with or without food, under physician supervision5 |
Strengths and directions on labels
The table is set at the top of the page
EFSA's adequate intake of 70 μg a day for all adults is set for phylloquinone (vitamin K1) only, not for menaquinones.6
Doses used in trials
No saved source gives a vitamin K2 dose specific to age or sex; the trials below give doses by arm, including in postmenopausal women7 and in men aged 65 to 74.4 Zhang 2020 (311 men and postmenopausal women aged 50 to 75, 1 year) is the only saved sex-split result: femoral neck bone loss was lower in postmenopausal women in the two 90 µg groups than with placebo, with no effects in men, and combining vitamin K2 with calcium and vitamin D3 brought no additional effects.8
| Trial | MK-7 dose and schedule | People | Length |
|---|---|---|---|
| Knapen 2013 | 180 μg per day, capsules, against placebo7 | 244 healthy postmenopausal women7 | 3 years7 |
| Rønn 2021 | 375 μg MK-7 or placebo daily, with vitamin D3 38 μg/day and calcium 800 mg/day in both arms9 | 142 postmenopausal women with osteopenia9 | 3 years9 |
| Zhang 2020 | Placebo, 50 or 90 µg per day, or vitamin K2 co-supplemented with calcium 500 mg and vitamin D3 10 µg per day8 | 311 Chinese men and postmenopausal women aged 50 to 758 | 1 year8 |
| Theuwissen 2012 | 10, 20, 45, 90, 180 or 360 μg daily in capsules, against placebo3 | 42 healthy Dutch men and women aged 18 to 453 | 12 weeks (registry NCT00483431)10 |
| AVADEC (Diederichsen 2022) | Tablets of 720 µg MK-7 plus 25 µg vitamin D daily, against matching placebo4 | 365 men aged 65 to 74 with aortic valve calcification scores ≥300 arbitrary units4 | 24 months4 |
| Zwakenberg 2019 | 360 µg MK-7 daily as 2 tablets with the evening meal, against placebo11 | Sixty-eight patients with type 2 diabetes and known cardiovascular disease11 | 6 mo11 |
Schedule, meals and cycles
The registry entry NCT00483431 for the Theuwissen 2012 trial (42 healthy volunteers) states the capsules were consumed once daily with either breakfast or dinner during a period of 12 weeks.10 No label says MK-7 needs fat beyond the oil carrier; EFSA's dietary fat statement is about phylloquinone (vitamin K1), not MK-7. The pack's search found no stated vitamin K2 cycle.
Vitamin D3 alongside K2
The Hatmanlabs softgel pairs 200 mcg of K2 with 250 mcg of vitamin D, and the YYUX drops pair 50 mcg of K2 with 500 IU of vitamin D3 per drop.12 AVADEC (365 men) paired 720 µg MK-7 with 25 µg of vitamin D, Rønn 2021 (142 women) gave both arms vitamin D3 38 μg and calcium 800 mg a day, and Zhang 2020 (311 adults) had one arm that combined vitamin K2 with calcium 500 mg and vitamin D3 10 µg a day.498
Warnings on labels
The Fosteum Plus label says that in a study of young, healthy anti-coagulated patients on warfarin, adding vitamin K2 decreased INR.5 The same label says the few published studies suggest doses of 300 μg/day may be required for clinically significant warfarin antagonism, but that these data vary greatly with dietary vitamin K intake; Primus Pharmaceuticals recommends that patients taking warfarin not use it, and if a physician feels its use is indicated, the INR is to be followed very carefully, probably at least twice weekly.5
Storage
The YYUX label says to store the bottle upright between 15°C and 25°C, and gives a shelf life of two years subject to storage conditions.2 The Fosteum Plus label says to store at room temperature, 59° to 86°F (15° to 30°C), protected from light and moisture, with the capsules kept in the original bottle until use.5 Neither label gives storage or stability after opening.
Frequently asked questions
How do you mix vitamin K2 drops?
The YYUX label says to take the drops directly or mixed with a beverage, with a dropper supplied.2 The pack's search for an oral powder label, a water volume or a maker's leaflet with mixing steps came up empty.
Can vitamin K2 drops be measured on a U-100 syringe?
The only per-volume figure is 50 mcg per drop on the YYUX label, with no mcg per mL and no drop volume, so no syringe mark can be worked from it.2
Is there a drug label for vitamin K2?
The pack's search of the US label database came up empty for an approved drug label for K2 as a medicine. A ClinicalTrials.gov search for the intervention vitamin K2 lists 100 studies.12
- Vitamin K2 (MK-7)Half-life, trials and doses.
- SupplementsMore supplement compounds.
- Units and dosingHow mcg, IU and syringe marks relate.
- How to take creatine monohydrateAnother oral supplement.
- Cholecalciferol dosageVitamin D3 label and trial doses.
- Omega-3 fish oil dosageAnother fat-soluble supplement.
References
- DailyMed. 83804-018 Hatmanlabs Vitamin D3&K2 with Coconut Oil 120 Softgels. 2026. dailymed.nlm.nih.gov
- DailyMed. YYUX ® ORGANIC LIQUID VITAMIN D3 + K2 DROPS SUPPLEMENT. 2020. dailymed.nlm.nih.gov
- PubMed. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. 2012. pubmed.ncbi.nlm.nih.gov
- PubMed Central. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. pmc.ncbi.nlm.nih.gov
- DailyMed. FOSTEUM PLUS ® Capsules calcium compounds (dicalcium malate and pentacalcium hydroxide triphosphate) (500 mg) phosphate (70 mg) genistein aglycone (27 mg) citrated zinc bisglycinate (20 mg) trans-menaquinone-7 (90 μg) cholecalciferol (400 IU). 2025. dailymed.nlm.nih.gov
- EFSA (EFSA Journal). Dietary reference values for vitamin K. 2017. pmc.ncbi.nlm.nih.gov
- PubMed. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. 2013. pubmed.ncbi.nlm.nih.gov
- PubMed. Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study. 2020. pubmed.ncbi.nlm.nih.gov
- PubMed. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. 2021. pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT00483431: Dose-finding Study for Vitamin K2 in Human Volunteers. 2007. clinicaltrials.gov
- PubMed Central. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial. 2019. pmc.ncbi.nlm.nih.gov
- ClinicalTrials.gov (US National Library of Medicine). ClinicalTrials.gov intervention search: vitamin K2. clinicaltrials.gov